OARSI/OMERACT Initiative to Define States of Severity and Indication for Joint Replacement in Hip and Knee Osteoarthritis. An OMERACT 10 Special Interest Group

Author:

GOSSEC LAURE,PATERNOTTE SIMON,BINGHAM CLIFTON O.,CLEGG DANIEL O.,COSTE PHILIPPE,CONAGHAN PHILIP G.,DAVIS AILEEN M.,GIACOVELLI GIAMPAOLO,GUNTHER KLAUS-PETER,HAWKER GILLIAN,HOCHBERG MARC C.,JORDAN JOANNE M.,KATZ JEFFREY N.,KLOPPENBURG MARGREET,LANZAROTTI ARTURO,LIM KEITH,LOHMANDER L. STEFAN,MAHOMED NIZAR N.,MAILLEFERT JEAN FRANCIS,MANNO REBECCA L.,MARCH LYN M.,MAZZUCA STEVEN A.,PAVELKA KAREL,PUNZI LEONARDO,ROOS EWA M.,ROVATI LUCIO C.,SHI HELEN,SINGH JASVINDER A.,SUAREZ-ALMAZOR MARIA E.,TAJANA-MESSI ELEONORA,DOUGADOS MAXIME

Abstract

Objective.To define pain and physical function cutpoints that would, coupled with structural severity, define a surrogate measure of “need for joint replacement surgery,” for use as an outcome measure for potential structure-modifying interventions for osteoarthritis (OA).Methods.New scores were developed for pain and physical function in knee and hip OA. A cross-sectional international study in 1909 patients was conducted to define data-driven cutpoints corresponding to the orthopedic surgeons’ indication for joint replacement. A post hoc analysis of 8 randomized clinical trials (1379 patients) evaluated the prevalence and validity of cutpoints, among patients with symptomatic hip/knee OA.Results.In the international cross-sectional study, there was substantial overlap in symptom levels between patients with and patients without indication for joint replacement; indeed, it was not possible to determine cutpoints for pain and function defining this indication. The post hoc analysis of trial data showed that the prevalence of cases that combined radiological progression, high level of pain, and high degree of function impairment was low (2%–12%). The most discriminatory cutpoint to define an indication for joint replacement was found to be [pain (0–100) + physical function (0–100) > 80].Conclusion.These results do not support a specific level of pain or function that defines an indication for joint replacement. However, a tentative cutpoint for pain and physical function levels is proposed for further evaluation. Potentially, this symptom level, coupled with radiographic progression, could be used to define “nonresponders” to disease-modifying drugs in OA clinical trials.

Publisher

The Journal of Rheumatology

Subject

Immunology,Immunology and Allergy,Rheumatology

Reference24 articles.

1. Concomitant therapy: an outcome variable for musculoskeletal disorders? Part 2: total joint replacement in osteoarthritis trials;Maillefert;J Rheumatol,2005

2. OMERACT/OARSI initiative to define states of severity and indication for joint replacement in hip and knee osteoarthritis;Gossec;J Rheumatol,2007

3. OARSI/OMERACT Criteria of Being Considered a Candidate for Total Joint Replacement in Knee/Hip Osteoarthritis as an Endpoint in Clinical Trials Evaluating Potential Disease Modifying Osteoarthritic Drugs

4. Development and preliminary psychometric testing of a new OA pain measure – an OARSI/OMERACT initiative

5. Multi-language translation and cross-cultural adaptation of the OARSI/OMERACT measure of intermittent and constant osteoarthritis pain (ICOAP)

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3